Ronac Mamtani, MD, MSCE

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-308
3400 Civic Center Blvd
Philadelphia, PA 19147
Office: 2156627606
Fax: (215) 349-8551
Education:
BS
Cornell University, 2002.
MD (Internal Medicine)
Stony Brook School of Medicine, 2006.
MS (Clinical Epidemiology)
University of Pennsylvania , 2012.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Shah M, Marmarelis ME, Mamtani R, Hennessy S.: Association Between Survival and Very High Versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-Small Cell Lung Cancer. Clin Lung Cancer 23(8), Dec 2022.

Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA.: NCCN GuidelinesĀ® Insights: Bladder Cancer, Version 2.2022. J Natl Compr Canc Netw 23(8), Dec 2022.

Herrera CD, Guerra CE, Narayan V, Guzzo TJ, Mamtani R, Lee DJ, Tasian GE, Talwar R: Financial toxicity in prostate cancer survivors: A national cross-sectional assessment of subjective financial burden. Urol Oncol Page: doi: 10.1016/j.urolonc.2022.10.014, Nov 2022.

Bange EM, Coughlin K, Li W, Moriarty E, Brown TJ, Shulman LN, Mamtani R : Accuracy of a Text Intervention to Minimize the Burden of Cancer Care Among Patients Treated With Immune Checkpoint Inhibitors. JAMA Netw Open 5(8), August 2022.

Nimgaonkar V, Hubbard RA, Carpenter EL, Mamtani R: Biomarker Testing, Treatment Uptake, and Survival Among Patients With Urothelial Cancer Receiving Gene-Targeted Therapy. JAMA Oncol 8(7), July 2022.

Margalit O, Yu S, Shacham-Shmueli E, Strauss G, Yang YX, Lawrence YR, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Mamtani R, Boursi B.: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma. Journal of Cancer Research and Clinical Oncology 148(7): 1703-1708, July 2022.

Vader DT, Parikh RB, Li H, Imai K, Hubbard RA, Mamtani R: Impact of label restriction on checkpoint-inhibitor use in bladder cancer and changes in mortality. JNCI Cancer Spectr. doi: 10.1093/jncics/pkac05: pkac050. Jul 9 2022 Notes: doi: 10.1093/jncics/pkac050. Online ahead of print.

Shah M, Hubbard RA, Mamtani R, Marmarelis ME, Hennessy S: Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practice. Pharmacoepidemiol Drug Saf Page: doi: 10.1002/pds.5487, Jun 7 2022 Notes: Online ahead of print.

Gotschall J, Major CK, Jacobs LA, Pucci DA, Blauch A, Palmer SC, Mamtani R : A novel approach to assessing the effects of smoking on treatment response rate in muscle-invasive bladder cancer. American Society of Clinical Oncology Annual Meeting, Chicago, IL Jun 2022 Notes: "Poster Presentation"

Takvorian SU, Chatterjee P, Mamtani R, Wu Y, Guerra C, Werner RM, Schpero W.: Association between state Medicaid policies and accrual of Black participants to cancer clinical trials. American Society of Clinical Oncology Annual Meeting, Chicago, IL Jun 2022 Notes: "Oral Presentation"

back to top
Last updated: 12/03/2022
The Trustees of the University of Pennsylvania